Revolutionary artificial enzymes transforming modern medicine

Nanozymes, artificial enzymes operating at the nanoscale, have emerged as one of the most promising breakthroughs in biomedical science and nanotechnology. Mimicking the catalytic activity of natural enzymes, nanozymes combine enhanced stability, tunable functions, and multifunctionality to address significant challenges in medical diagnostics, therapeutics, and drug delivery. As highlighted in the 2025 Top 10 Emerging Technologies report by the World Economic Forum and Frontiers, nanozymes are poised to revolutionize medical applications by enabling faster, safer, and more cost-effective healthcare solutions.

What are nanozymes and how do they work?

Nanozymes are nanomaterials engineered to catalyze biological reactions akin to natural enzymes such as peroxidase, catalase, or oxidase. Unlike protein-based enzymes, nanozymes remain stable under harsh environmental conditions including extreme pH, temperature, and oxidative stress. Crafted from diverse nanostructures such as metal oxides, metal-organic frameworks, graphene derivatives, and carbon-based nanoparticles, nanozymes exhibit customizable catalytic activities through tuning their composition, size, shape, and surface chemistry¹.

Advantages over natural enzymes

Natural enzymes offer high specificity but are hindered by limitations such as fragility, cost of production, and short shelf life. Nanozymes overcome these barriers by:

• Enhanced stability – resistant to denaturation from temperature and pH fluctuations.
• Cost efficiency – scalable synthesis methods enable large-scale production at lower costs.
• Multifunctionality – capable of mimicking several enzyme types within a single nanoparticle system.
• Tunable activity – catalytic activity can be adjusted via surface modifications and doping.

Key biomedical applications

Sensitive biosensing and diagnostics

Nanozymes are widely used to develop advanced biosensors for early and rapid disease diagnosis. Their catalytic properties improve detection of physiological markers like glucose, uric acid, and glutathione, as well as biomarkers for cancers, infections, and cardiovascular diseases. Methods include colorimetric assays, electrochemical sensors, fluorescence, chemiluminescence, and hybrid CRISPR-based detection systems. These technologies enable point-of-care diagnostics with high sensitivity, specificity, and quick turnaround times².

Antibacterial, antiviral, and antifungal therapies

With rising antibiotic resistance, nanozymes offer innovative antimicrobial strategies that avoid resistance mechanisms. They function via catalytic production of reactive oxygen species (ROS) that disrupt microbial membranes and biofilms. Multifunctional nanozymes synergize enzyme-like activities to simultaneously combat bacteria, viruses, and fungi. Examples include combinations mimicking oxidase, peroxidase, superoxide dismutase, and catalase that target diverse pathogens with minimal toxicity and side effects .

Antioxidation and tissue protection

Many pathological conditions arise from oxidative stress caused by reactive oxygen species damaging cellular structures. Nanozymes exhibit antioxidant enzyme-mimicking activities that scavenge ROS, thus protecting tissues from inflammation, ischemia-reperfusion injury, neurodegenerative diseases, and cancer progression. Functionalized nanozymes are being developed to cross biological barriers such as the blood-brain barrier, offering novel therapies for Parkinson’s disease and stroke.

Targeted drug delivery

Nanozymes are incorporated in smart drug delivery platforms that respond to specific stimuli (pH, temperature, ROS levels) to release therapeutic agents precisely at diseased sites. This enhances treatment efficacy while reducing systemic toxicity, improving patient outcomes especially in cancer and inflammatory diseases³.

Current challenges and future directions

Despite enormous promise, nanozyme research faces challenges:

• Controlled synthesis – producing nanozymes with uniform size, predictable catalytic activity, and biocompatibility requires refined fabrication techniques.
• Mechanistic understanding – elucidating precise catalytic pathways is essential for rational design.
• Safety and biocompatibility – comprehensive toxicity and immunogenicity studies are critical before clinical translation.
• Integrated platforms – combining nanozymes with biosensors, imaging, and delivery systems for multifunctional theranostics is ongoing research focus.
• Scale-up and commercialization – developing cost-effective, reproducible manufacturing processes for wider adoption.

Future research leveraging artificial intelligence, machine learning, and advanced materials science will accelerate development of tailor-made nanozymes addressing emerging medical needs. Integration with personalized medicine and regenerative therapies opens new horizons for healthcare innovation.

1. https://advanced.onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202402066 ↩︎
2. https://pubs.aip.org/aip/apm/article/12/10/100401/3315248/Nanozymes-for-biomedical-applications ↩︎
3. onlinelibrary.wiley.com/doi/full/10.1002/adhm.202402066 ↩︎